79932-20-0 Usage
General Description
4-isopropyl-1,3-thiazol-2-amine is a chemical compound with the molecular formula C6H12N2S. It is a member of the thiazole family, which is characterized by a five-membered ring containing four carbon atoms, one sulfur atom, and one nitrogen atom. 4-isopropyl-1,3-thiazol-2-amine is classified as an amine due to the presence of an amino group (-NH2) attached to the thiazole ring. 4-isopropyl-1,3-thiazol-2-amine is used in organic synthesis and medicinal chemistry as a building block for the creation of various pharmaceutical and agrochemical products. It has potential applications in the development of drugs targeting a wide range of biological processes. Additionally, this compound may be used as a starting material for the synthesis of other related thiazole derivatives with diverse chemical and biological properties.
Check Digit Verification of cas no
The CAS Registry Mumber 79932-20-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,9,9,3 and 2 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 79932-20:
(7*7)+(6*9)+(5*9)+(4*3)+(3*2)+(2*2)+(1*0)=170
170 % 10 = 0
So 79932-20-0 is a valid CAS Registry Number.
InChI:InChI=1/C6H10N2S/c1-4(2)5-3-9-6(7)8-5/h3-4H,1-2H3,(H2,7,8)
79932-20-0Relevant articles and documents
MODIFIED PROTEINS AND PROTEIN DEGRADERS
-
, (2021/12/08)
Provided herein are compounds, pharmaceutical compositions, and methods for binding or degrading target proteins. Further provided herein are compounds having a DNA damage-binding protein 1 (DDB1) binding moiety. Some such embodiments include a linker. Some such embodiments include a target protein binding moiety. Further provided herein are ligand-DDB1 complexes. Further provided herein are in vivo modified DDB1 proteins.
NEW BICYCLIC COMPOUND FOR MODULATING G PROTEIN-COUPLED RECEPTORS
-
, (2012/07/27)
The present invention relates to a bicyclic compound for modulating G protein-coupled receptors. The inventive compound provides preventing or treating a disease associated with the modulation of G protein-coupled receptors, particularly GPR119 G protein-coupled receptors.
NEW AMINOTHIAZOLES AS FBPASE INHIBITORS FOR DIABETES
-
, (2009/06/27)
Compounds of formula (I) as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R3 have the significance given in claim 1 and which can be used in the form of pharmaceutical compositions.
